BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright ©The Author(s) 2025.
World J Radiol. Dec 28, 2025; 17(12): 112986
Published online Dec 28, 2025. doi: 10.4329/wjr.v17.i12.112986
Table 1 Parameters assessed on pre-operative transthoracic echocardiography
Parameter
Assessment of normal atrio-ventricular and ventriculo-arterial relations
Spatial relations of the great arteries
Adequacy of the size of the VSD and the routability of the left ventricle to the aorta. Additional VSDs can also be evaluated
Function of the aortic valve
Level of obstruction in RVOT
Size of the pulmonary annulus, main pulmonary artery, and branch PAs
Coronary origin and presence of any anomalous branch crossing the RVOT
In the presence of pulmonary atresia, the adequacy of native PA size and blood supply to them (via patent ductus arteriosus / aortopulmonary collaterals)
Systolic and diastolic function of the ventricles
Aortic arch abnormalities
Table 2 Key reporting elements in magnetic resonance imaging of post-operative tetralogy of Fallot
Parameter
RVOTResidual obstruction or dyskinesia/aneurysm
Location, extent, and size
Functional assessment of RV and RVOTQuantification of pulmonary regurgitation fraction
Right ventricle volume and function assessment
Screening for tricuspid regurgitation
Pulmonary artery stenosisSite
Extent
Degree
Post-stenotic dilatation: Present/absent
Residual VSDLocation and size
Quantification of shunt (Qp/Qs)
Aortic root assessmentAortic root dilatation
Quantification of aortic regurgitation
Left ventricle volume and functional assessment
Table 3 Key computed tomography angiography reporting elements in pre-operative tetralogy of Fallot
Parameter
SitusSolitus/ambiguous
Cardiac positionLevocardia/mesocardiac/dextrocardia
VSDSize
SitePerimembranous/muscular
Aortic override50% or > 50%
ASDPresent/absent
Status of the main pulmonary arteryAtresia/stenosis
Site of stenosisInfundibular/valvular/supravalvular
Pulmonary valvePresent/absent
Status of branch pulmonary arteriesConfluent/isolated
SizeGood-sized/small-sized (Mcgoon ratio and Nakata index1)
Collateral vesselsPDASize and opacification
Presence of proximal/distal end stenosis
Aortopulmonary collateralsOrigin (DTA/aortic arch branches, etc.)
Calibre (major/small); o’clock position, course and supply
Aortic archSideRight/Left
Branching patternLeft: Normal; bovine; aberrant right subclavian artery; truncus bicaroticus; direct origin of the vertebral artery
Right: Mirror image; independent origin of the vertebral artery; aberrant left subclavian artery
Coronary arteryOriginSeparate sinuses/common sinus/LAD originating from RCA
CourseCourse anterior to RVOT; inter-arterial course; hypertrophied conus branch of RCA coursing anterior to the infundibulum
Table 4 Imaging modalities and their use in different stages of care in patients with tetralogy of Fallot
Stage of care
Imaging modality
Information provided
Advantages
At initial diagnosisTTEDefines the position of the VSD, degree of aortic override, and location and severity of the RVOT obstructionWidely available, safe (no radiation), and assesses the basic defects
CMRAssessment of pulmonary arteries- size/confluence; MAPCAsHigh-resolution, objective data on ventricular volumes, function, and pulmonary artery anatomy without using ionizing radiation
CT angiography - as an alternative to CMR, however choice depends upon centre to centre; should preferably be an ECG-gated acquisitionDetailed assessment of pulmonary artery anatomy and branches; MAPCAs; coronary arteries anatomy; additional defects: ASD; PAPVC, muscular VSDHigh spatial and temporal resolution, compared with CMR, less time is required for data acquisition
Post-surgical shuntsCT angiographyShunt patency, stenosisHigh accuracy
Post-intra-cardiac repairCMRQuantification of PR; RV volume and function; complications: RVOT aneurysms and myocardial fibrosis Highly accurate and gold standard for volumetry
Catheter angiographyAssessment of residual stenosis in pulmonary arteries and management (balloon dilation or stenting); management of residual VSDs; percutaneous PVR proceduresDiagnosis and therapeutic interventions